Check-Cap Ltd. (CHEK) Dividend History

Check-Cap Ltd. is a medical technology company specializing in developing non-invasive, capsule-shaped imaging devices for early detection of gastrointestinal diseases. The company's flagship product is a swallowable capsule equipped with advanced imaging and sensing technologies designed to improve the accuracy and comfort of gastrointestinal diagnostics. Check-Cap focuses on providing minimally invasive, cost-effective solutions to enhance patient care and streamline medical workflows in GI health.

Dividend History

Check-Cap Ltd. currently does not pay dividends

Company News

  • MediPharm Labs warns shareholders about the involvement of three director nominees from Apollo Technology Capital Corporation in the troubled events at Check-Cap Ltd., raising concerns about their suitability to take control of the MediPharm board.

    GlobeNewswire Inc.
  • Apollo Technology Capital, a major shareholder of MediPharm Labs, poses critical questions for the company's management to address on their upcoming conference call, citing concerns over MediPharm's poor performance, lack of transparency, and excessive executive compensation.

    Benzinga
  • Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ: STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ: CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results. OpGen, Inc. (NASDAQ: OPGN) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million. Mesoblast Limited (NASDAQ: MESO) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease. Praxis Precision Medicines Inc (NASDAQ: PRAX) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI. Viking Therapeutics ...

    Benzinga
  • Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Check-Cap Ltd. (NASDAQ: CHEK) shares gained 38.3% to $2.67 in pre-market trading. Nobul AI Corp entered into business combination agreement with Check-Cap. C3is Inc. (NASDAQ: CISS) rose 35.2% to $0.0476 in pre-market trading. C3is is expected to release its fourth quarter financial results before the opening bell on March 26, 2024. OpGen, Inc. (NASDAQ: OPGN) gained 30.4% to $0.6196 in pre-market trading after the company announced David Lazar will invest $3 million in preferred stock and take over as CEO. Mesoblast Limited (NASDAQ: MESO) gained 23.2% to $2.71 in pre-market trading. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory ...

    Benzinga
    Featured Companies: BREA BZFD CISS DNUT GWAV INTJ IVVD STOK SXTP TIVC VIVK WPRT
  • Gainers PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share. Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 39.1% to $0.0932. Tivic Health Systems shares jumped 80% on Wednesday after the company announced its funded study started enrollment for its non-invasive bioelectronic device approach to vagus nerve stimulation. Sunlight Financial Holdings Inc. (NYSE: SUNL) climbed 36.9% to $0.2101 after declining 8% on Wednesday. Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares rose 30.2% to $5.00. Advanced Health Intelligence said it obtained overseas R&D reimbursement under Australia's research and development tax incentive scheme. Troika Media Group, Inc. (NASDAQ: TRKA) climbed 29% to $1.3794. LSI Industries Inc. (NASDAQ: LYTS) gained 21.8% to $15.55 following better-than-expected fourth-quarter results. BioNexus Gene Lab Corp. (NASDAQ: BGLC) surged 22.2% to $0.88. ETAO International Co., Ltd. (NASDAQ: ETAO) rose 21% to $0.5600. Ascent Solar Technologies, Inc. (NASDAQ: ASTI) gained 18.8% to $0.0799. Super Group (SGHC) Limited (NASDAQ: SGHC) jumped 18.7% to $3.4785 following strong quarterly results. Catalyst Biosciences, Inc. (NASDAQ: CBIO) jumped 16.2% to $0.51. Recruiter.com Group, Inc. (NASDAQ: RCRT) gained 15.1% to $0.2139. Job Mobz announced plans to acquire iconic Recruiter.com brand in cash and stock deal. Gambling.com Group Limited (NASDAQ: GAMB) gained 14.3% to $14.51 as the company posted upbeat second-quarter results and raised FY23 guidance. LQR House Inc. (NASDAQ: LQR) surged 13.5% to ...

    Benzinga
Dividend data last updated 06/07/2025 10:31:19 UTC